Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer

DI Rosenthal, JS Lewin, A Eisbruch - Journal of clinical oncology, 2006 - ascopubs.org
Safe, successful swallowing depends on complex events affected by head and neck cancers
and their treatment. This article reviews the swallowing process, how it is affected by …

[HTML][HTML] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

JA Bonner, PM Harari, J Giralt, N Azarnia… - … England Journal of …, 2006 - Mass Medical Soc
Background We conducted a multinational, randomized study to compare radiotherapy
alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal …

Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum

DM Brizel, R Esclamado - Journal of clinical oncology, 2006 - ascopubs.org
Radiotherapy and concurrent chemotherapy (CRT) is superior to radiotherapy alone for the
treatment of locally advanced, nonmetastatic squamous carcinoma of the head and neck …

Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer …

D Rischin, RJ Hicks, R Fisher, D Binns… - Journal of Clinical …, 2006 - ascopubs.org
Purpose To determine the association between tumor hypoxia, treatment regimen, and
locoregional failure (LRF) in patients with stage III or IV squamous cell carcinoma of the …

[HTML][HTML] A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced …

W Budach, T Hehr, V Budach, C Belka, K Dietz - BMC cancer, 2006 - Springer
Background Former meta-analyses have shown a survival benefit for the addition of
chemotherapy (CHX) to radiotherapy (RT) and to some extent also for the use of …

Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution

J Yi, L Gao, X Huang, S Li, J Luo, W Cai, J Xiao… - International Journal of …, 2006 - Elsevier
Purpose: To report on our experience in the treatment of nasopharyngeal carcinoma (NPC)
by radical radiotherapy alone in our institution during the last decade. Methods and …

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a …

DG Pfister, YB Su, DH Kraus, SL Wolden… - Journal of clinical …, 2006 - ascopubs.org
Purpose Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth
factor receptor. Cetuximab has activity in squamous cell carcinoma and enhances both …

Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience

FF de Arruda, DR Puri, J Zhung, A Narayana… - International Journal of …, 2006 - Elsevier
Purpose: To review the Memorial Sloan-Kettering Cancer Center's experience in using
intensity-modulated radiation therapy (IMRT) for the treatment of oropharyngeal cancer …

Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence

NP Nguyen, C Frank, CC Moltz, P Vos, HJ Smith… - Radiotherapy and …, 2006 - Elsevier
BACKGROUND AND PURPOSE: We would like to assess the prevalence of aspiration
before and following chemoradiation for head and neck cancer. PATIENTS AND METHODS …

Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting

PJ Stiff, C Emmanouilides, WI Bensinger… - Journal of Clinical …, 2006 - ascopubs.org
Purpose To describe patient-reported outcomes of mouth and throat soreness (MTS) and
related sequelae on daily activities from a phase III study of palifermin in the autologous …